{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:29:39Z","timestamp":1789655379694,"version":"4.0.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM072631"],"award-info":[{"award-number":["GM072631"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00441-026-04074-5","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:04:06Z","timestamp":1778652246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disrupting oncogenic signaling in triple negative breast cancer: The interplay of Cx43, Pyk2, and Src in MDA-MB-231 cells"],"prefix":"10.1007","volume":"404","author":[{"given":"Li","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Spagnol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Sorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"4074_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc.2016.105","volume":"16","author":"T Aasen","year":"2016","unstructured":"Aasen T, Mesnil M, Naus CC, Lampe PD, Laird DW (2016) Gap junctions and cancer: communicating for 50 years. Nat Rev Cancer 16:775\u2013788","journal-title":"Nat Rev Cancer"},{"key":"4074_CR2","doi-asserted-by":"publisher","unstructured":"Aasen T, Johnstone S, Vidal-Brime L, Lynn KS, Koval M. (2018) Connexins: synthesis, post-translational modifications, and trafficking in health and disease. Int J Mol Sci. 19(5). https:\/\/doi.org\/10.3390\/ijms19051296","DOI":"10.3390\/ijms19051296"},{"key":"4074_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157073","volume":"11","author":"C Ambrosi","year":"2016","unstructured":"Ambrosi C, Ren C, Spagnol G, Cavin G, Cone A, Grintsevich EE, Sosinsky GE, Sorgen PL (2016) Connexin43 forms supramolecular complexes through non-overlapping binding sites for Drebrin, Tubulin, and ZO-1. PLoS ONE 11:e0157073","journal-title":"PLoS ONE"},{"key":"4074_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104417","volume":"201","author":"R Banerjee","year":"2024","unstructured":"Banerjee R, Maitra I, Bhattacharya T, Banerjee M, Ramanathan G, Rayala SK, Venkatraman G, Rajeswari D (2024) Next-generation biomarkers for prognostic and potential therapeutic enhancement in triple negative breast cancer. Crit Rev Oncol Hematol 201:104417","journal-title":"Crit Rev Oncol Hematol"},{"key":"4074_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0898-6568(01)00253-4","volume":"14","author":"D Beitner-Johnson","year":"2002","unstructured":"Beitner-Johnson D, Ferguson T, Rust RT, Kobayashi S, Millhorn DE (2002) Calcium-dependent activation of Pyk2 by hypoxia. Cell Signal 14:133\u2013137","journal-title":"Cell Signal"},{"key":"4074_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biocel.2017.03.014","volume":"87","author":"AHL Bong","year":"2017","unstructured":"Bong AHL, Monteith GR (2017) Breast cancer cells: focus on the consequences of epithelial-to-mesenchymal transition. Int J Biochem Cell Biol 87:23\u201326","journal-title":"Int J Biochem Cell Biol"},{"key":"4074_CR7","doi-asserted-by":"publisher","unstructured":"Busby M, Hallett MT, Plante I\u00a0(2018) The complex subtype-dependent role of connexin 43 (GJA1) in breast cancer. Int J Mol Sci 19(3). https:\/\/doi.org\/10.3390\/ijms19030693","DOI":"10.3390\/ijms19030693"},{"key":"4074_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature18268","volume":"533","author":"Q Chen","year":"2016","unstructured":"Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob L, Patwa R, Shah H, Xu K, Cross JR, Massague J (2016) Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533:493\u2013498","journal-title":"Nature"},{"key":"4074_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621\u2013681","journal-title":"Pharmacol Rev"},{"key":"4074_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, Daidone MG, Dupont S, Basso G, Bicciato S, Piccolo S (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147:759\u2013772","journal-title":"Cell"},{"key":"4074_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1615\/CritRevOncog.v17.i2.20","volume":"17","author":"H Creedon","year":"2012","unstructured":"Creedon H, Brunton VG (2012) Src kinase inhibitors: promising cancer therapeutics? Crit Rev Oncog 17:145\u2013159","journal-title":"Crit Rev Oncog"},{"key":"4074_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.628690","volume":"12","author":"C Dong","year":"2021","unstructured":"Dong C, Wu J, Chen Y, Nie J, Chen C (2021) Activation of PI3K\/AKT\/mTOR pathway causes drug resistance in breast cancer. Front Pharmacol 12:628690","journal-title":"Front Pharmacol"},{"key":"4074_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-6-20","volume":"6","author":"MK Elzarrad","year":"2008","unstructured":"Elzarrad MK, Haroon A, Willecke K, Dobrowolski R, Gillespie MN, Al-Mehdi AB (2008) Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 6:20","journal-title":"BMC Med"},{"key":"4074_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2741\/3706","volume":"16","author":"Q Felty","year":"2011","unstructured":"Felty Q (2011) Redox sensitive Pyk2 as a target for therapeutics in breast cancer. Front Biosci (Landmark Ed) 16:568\u2013577","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4074_CR15","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.1021\/bi047629p","volume":"44","author":"Q Felty","year":"2005","unstructured":"Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, Roy D (2005) Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 44:6900\u20136909","journal-title":"Biochemistry"},{"key":"4074_CR16","doi-asserted-by":"publisher","first-page":"36943","DOI":"10.1074\/jbc.M403952200","volume":"279","author":"CT Fu","year":"2004","unstructured":"Fu CT, Bechberger JF, Ozog MA, Perbal B, Naus CC (2004) CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J Biol Chem 279:36943\u201336950","journal-title":"J Biol Chem"},{"key":"4074_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2023.07.006","volume":"34","author":"H Gil-Henn","year":"2024","unstructured":"Gil-Henn H, Girault JA, Lev S (2024) PYK2, a hub of signaling networks in breast cancer progression. Trends Cell Biol 34:312\u2013326","journal-title":"Trends Cell Biol"},{"key":"4074_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a002576","volume":"1","author":"DA Goodenough","year":"2009","unstructured":"Goodenough DA, Paul DL (2009) Gap junctions. Cold Spring Harb Perspect Biol 1:a002576","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4074_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2016.02.008","volume":"374","author":"CL Grek","year":"2016","unstructured":"Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES (2016) Connexin 43, breast cancer tumor suppressor: missed connections? Cancer Lett 374:117\u2013126","journal-title":"Cancer Lett"},{"key":"4074_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18:533\u2013548","journal-title":"Nat Rev Cancer"},{"key":"4074_CR21","first-page":"3927","volume":"30","author":"B Heiniger","year":"2010","unstructured":"Heiniger B, Gakhar G, Prasain K, Hua DH, Nguyen TA (2010) Second-generation substituted quinolines as anticancer drugs for breast cancer. Anticancer Res 30:3927\u20133932","journal-title":"Anticancer Res"},{"key":"4074_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.exer.2007.08.019","volume":"85","author":"RR Hodges","year":"2007","unstructured":"Hodges RR, Horikawa Y, Rios JD, Shatos MA, Dartt DA (2007) Effect of protein kinase C and Ca2+ on p42\/p44 MAPK, Pyk2, and Src activation in rat conjunctival goblet cells. Exp Eye Res 85:836\u2013844","journal-title":"Exp Eye Res"},{"key":"4074_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biology11071023","author":"M Huang","year":"2022","unstructured":"Huang M, Song A, Chen X, Ishtiaq S, Wang C, Hadsell DL, Wang QA, Zhu Y (2022) Maternal adipocyte Connexin43 gap junctions affect breastmilk lactose levels and neonate growth in mice. Biology (Basel).\u00a011(7).\u00a0https:\/\/doi.org\/10.3390\/biology11071023","journal-title":"Biology (Basel)"},{"key":"4074_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.117877","volume":"112","author":"R Islam","year":"2024","unstructured":"Islam R, Yen KP, Rani NM, Hossain MS (2024) Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer. Bioorg Med Chem 112:117877","journal-title":"Bioorg Med Chem"},{"key":"4074_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1091\/mbc.E17-06-0406","volume":"29","author":"CC James","year":"2018","unstructured":"James CC, Zeitz MJ, Calhoun PJ, Lamouille S, Smyth JW (2018) Altered translation initiation of Gja1 limits gap junction formation during epithelial-mesenchymal transition. Mol Biol Cell 29:797\u2013808","journal-title":"Mol Biol Cell"},{"key":"4074_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<37::AID-PATH966>3.0.CO;2-D","volume":"184","author":"S Jamieson","year":"1998","unstructured":"Jamieson S, Going JJ, D\u2019Arcy R, George WD (1998) Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol 184:37\u201343","journal-title":"J Pathol"},{"key":"4074_CR27","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.bbamem.2011.11.016","volume":"1818","author":"P Kameritsch","year":"2012","unstructured":"Kameritsch P, Pogoda K, Pohl U (2012) Channel-independent influence of connexin 43 on cell migration. Biochim Biophys Acta 1818:1993\u20132001","journal-title":"Biochim Biophys Acta"},{"key":"4074_CR28","first-page":"439","volume":"62","author":"L Kanczuga-Koda","year":"2003","unstructured":"Kanczuga-Koda L, Sulkowska M, Koda M, Reszec J, Famulski W, Baltaziak M, Sulkowski S (2003) Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland. Folia Morphol (Warsz) 62:439\u2013442","journal-title":"Folia Morphol (Warsz)"},{"key":"4074_CR29","doi-asserted-by":"publisher","unstructured":"Kazan JM, El-Saghir J, Saliba J, Shaito A, Jalaleddine N, El-Hajjar L, Al-Ghadban S, Yehia L, Zibara K, El-Sabban M\u00a0(2019) Cx43 expression correlates with breast cancer metastasis in MDA-MB-231 Cells In Vitro. In a mouse xenograft model and in human breast cancer tissues. Cancers (Basel). 11(4). https:\/\/doi.org\/10.3390\/cancers11040460","DOI":"10.3390\/cancers11040460"},{"key":"4074_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1005-z","volume":"9","author":"A Kedan","year":"2018","unstructured":"Kedan A, Verma N, Saroha A, Shreberk-Shaked M, Muller AK, Nair NU, Lev S (2018) PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death Dis 9:985","journal-title":"Cell Death Dis"},{"key":"4074_CR31","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/CIRCRESAHA.108.190454","volume":"104","author":"F Kieken","year":"2009","unstructured":"Kieken F, Mutsaers N, Dolmatova E, Virgil K, Wit AL, Kellezi A, Hirst-Jensen BJ, Duffy HS, Sorgen PL (2009) Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ Res 104:1103\u20131112","journal-title":"Circ Res"},{"key":"4074_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","volume":"6","author":"LC Kim","year":"2009","unstructured":"Kim LC, Song L, Haura EB (2009) Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6:587\u2013595","journal-title":"Nat Rev Clin Oncol"},{"key":"4074_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/BJ20070665","volume":"410","author":"T Kohno","year":"2008","unstructured":"Kohno T, Matsuda E, Sasaki H, Sasaki T (2008) Protein-tyrosine kinase CAKbeta\/PYK2 is activated by binding Ca2+\/calmodulin to FERM F2 alpha2 helix and thus forming its dimer. Biochem J 410:513\u2013523","journal-title":"Biochem J"},{"key":"4074_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-94-007-4186-7_9","volume":"60","author":"AP Kowalczyk","year":"2012","unstructured":"Kowalczyk AP, Nanes BA (2012) Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling. Subcell Biochem 60:197\u2013222","journal-title":"Subcell Biochem"},{"key":"4074_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183503","volume":"1863","author":"D Kyuno","year":"2021","unstructured":"Kyuno D, Takasawa A, Kikuchi S, Takemasa I, Osanai M, Kojima T (2021) Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. Biochim Biophys Acta Biomembr 1863:183503","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4074_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/BJ20051922","volume":"394","author":"DW Laird","year":"2006","unstructured":"Laird DW (2006) Life cycle of connexins in health and disease. Biochem J 394:527\u2013543","journal-title":"Biochem J"},{"key":"4074_CR37","first-page":"4104","volume":"59","author":"DW Laird","year":"1999","unstructured":"Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA (1999) Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 59:4104\u20134110","journal-title":"Cancer Res"},{"key":"4074_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4074_CR39","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1357-2725(03)00264-4","volume":"36","author":"PD Lampe","year":"2004","unstructured":"Lampe PD, Lau AF (2004) The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36:1171\u20131186","journal-title":"Int J Biochem Cell Biol"},{"key":"4074_CR40","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1158\/0008-5472.CAN-09-3281","volume":"70","author":"S Langlois","year":"2010","unstructured":"Langlois S, Cowan KN, Shao Q, Cowan BJ, Laird DW (2010) The tumor-suppressive function of Connexin43 in keratinocytes is mediated in part via interaction with caveolin-1. Cancer Res 70:4222\u20134232","journal-title":"Cancer Res"},{"key":"4074_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415475","author":"D Lee","year":"2022","unstructured":"Lee D, Hong JH (2022) Activated PyK2 and its associated molecules transduce cellular signaling from the cancerous milieu for cancer metastasis. Int J Mol Sci.\u00a023(24).\u00a0https:\/\/doi.org\/10.3390\/ijms232415475","journal-title":"Int J Mol Sci"},{"key":"4074_CR42","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1172\/JCI200418046","volume":"114","author":"S Li","year":"2004","unstructured":"Li S, Sato S, Yang X, Preisig PA, Alpern RJ (2004) Pyk2 activation is integral to acid stimulation of sodium\/hydrogen exchanger 3. J Clin Invest 114:1782\u20131789","journal-title":"J Clin Invest"},{"key":"4074_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s10585-008-9208-9","volume":"25","author":"Z Li","year":"2008","unstructured":"Li Z, Zhou Z, Welch DR, Donahue HJ (2008) Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis 25:893\u2013901","journal-title":"Clin Exp Metastasis"},{"key":"4074_CR44","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/jcp.26164","volume":"233","author":"H Li","year":"2018","unstructured":"Li H, Zhang D, Yu J, Liu H, Chen Z, Zhong H, Wan Y (2018) CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer. J Cell Physiol 233:3207\u20133217","journal-title":"J Cell Physiol"},{"key":"4074_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1083\/jcb.200102027","volume":"154","author":"R Lin","year":"2001","unstructured":"Lin R, Warn-Cramer BJ, Kurata WE, Lau AF (2001) v-Src phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap junctional communication. J Cell Biol 154:815\u2013827","journal-title":"J Cell Biol"},{"key":"4074_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1042\/BST20150034","volume":"43","author":"C Lorraine","year":"2015","unstructured":"Lorraine C, Wright CS, Martin PE (2015) Connexin43 plays diverse roles in co-ordinating cell migration and wound closure events. Biochem Soc Trans 43:482\u2013488","journal-title":"Biochem Soc Trans"},{"key":"4074_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01596-y","volume":"24","author":"J Luo","year":"2022","unstructured":"Luo J, Zou H, Guo Y, Tong T, Ye L, Zhu C, Deng L, Wang B, Pan Y, Li P (2022) SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Res 24:99","journal-title":"Breast Cancer Res"},{"key":"4074_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1042\/BJ20111144","volume":"446","author":"AI Macdonald","year":"2012","unstructured":"Macdonald AI, Sun P, Hernandez-Lopez H, Aasen T, Hodgins MB, Edward M, Roberts S, Massimi P, Thomas M, Banks L, Graham SV (2012) A functional interaction between the MAGUK protein hDlg and the gap junction protein connexin 43 in cervical tumour cells. Biochem J 446:9\u201321","journal-title":"Biochem J"},{"key":"4074_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061448","author":"S Martellucci","year":"2020","unstructured":"Martellucci S, Clementi L, Sabetta S, Mattei V, Botta L, Angelucci A (2020) Src family kinases as therapeutic targets in advanced solid tumors: What we have learned so far. Cancers (Basel).\u00a012(6).\u00a0https:\/\/doi.org\/10.3390\/cancers12061448","journal-title":"Cancers (Basel)"},{"key":"4074_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbamem.2012.05.014","volume":"1828","author":"L Matsuuchi","year":"2013","unstructured":"Matsuuchi L, Naus CC (2013) Gap junction proteins on the move: connexins, the cytoskeleton and migration. Biochim Biophys Acta 1828:94\u2013108","journal-title":"Biochim Biophys Acta"},{"key":"4074_CR51","doi-asserted-by":"publisher","first-page":"9886","DOI":"10.1158\/0008-5472.CAN-05-4302","volume":"66","author":"E McLachlan","year":"2006","unstructured":"McLachlan E, Shao Q, Wang HL, Langlois S, Laird DW (2006) Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 66:9886\u20139894","journal-title":"Cancer Res"},{"key":"4074_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037374","volume":"7","author":"A Mendoza-Naranjo","year":"2012","unstructured":"Mendoza-Naranjo A, Cormie P, Serrano AE, Hu R, O\u2019Neill S, Wang CM, Thrasivoulou C, Power KT, White A, Serena T, Phillips AR, Becker DL (2012) Targeting Cx43 and N-cadherin, which are abnormally upregulated in venous leg ulcers, influences migration, adhesion and activation of Rho GTPases. PLoS ONE 7:e37374","journal-title":"PLoS ONE"},{"key":"4074_CR53","doi-asserted-by":"publisher","first-page":"53350","DOI":"10.18632\/oncotarget.10804","volume":"7","author":"Y Merrouche","year":"2016","unstructured":"Merrouche Y, Fabre J, Cure H, Garbar C, Fuselier C, Bastid J, Antonicelli F, Al-Daccak R, Bensussan A, Giustiniani J (2016) IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells. Oncotarget 7:53350\u201353361","journal-title":"Oncotarget"},{"key":"4074_CR54","doi-asserted-by":"publisher","unstructured":"Ming J, Zhou Y, Du J, Fan S, Pan B, Wang Y, Fan L, Jiang J (2015) Identification of miR-200a as a novel suppressor of connexin 43 in breast cancer cells. Biosci Rep.\u00a035(5).\u00a0https:\/\/doi.org\/10.1042\/BSR20150153","DOI":"10.1042\/BSR20150153"},{"key":"4074_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/cbir.1996.0016","volume":"20","author":"P Monaghan","year":"1996","unstructured":"Monaghan P, Moss D (1996) Connexin expression and gap junctions in the mammary gland. Cell Biol Int 20:121\u2013125","journal-title":"Cell Biol Int"},{"key":"4074_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105696","volume":"9","author":"AK Muller","year":"2022","unstructured":"Muller AK, Kohler UA, Trzebanski S, Vinik Y, Raj HM, Girault JA, Ben-Chetrit N, Maraver A, Jung S, Lev S (2022) Mouse modeling dissecting macrophage-breast cancer communication uncovered roles of PYK2 in macrophage recruitment and breast tumorigenesis. Adv Sci (Weinh) 9:e2105696","journal-title":"Adv Sci (Weinh)"},{"key":"4074_CR57","first-page":"5028","volume":"63","author":"A Myoui","year":"2003","unstructured":"Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T (2003) C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63:5028\u20135033","journal-title":"Cancer Res"},{"key":"4074_CR58","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrc2841","volume":"10","author":"CC Naus","year":"2010","unstructured":"Naus CC, Laird DW (2010) Implications and challenges of connexin connections to cancer. Nat Rev Cancer 10:435\u2013441","journal-title":"Nat Rev Cancer"},{"key":"4074_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030482","author":"EE Newton","year":"2022","unstructured":"Newton EE, Mueller LE, Treadwell SM, Morris CA, Machado HL (2022) Molecular targets of triple-negative breast cancer: Where do we stand? Cancers (Basel).\u00a014(3).\u00a0https:\/\/doi.org\/10.3390\/cancers14030482","journal-title":"Cancers (Basel)"},{"key":"4074_CR60","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E, Anchondo-Nunez P, Acuna-Aguilar LE, Gomez-Valles FO, Ramirez-Valdespino CA\u00a0(2022) Subtypes of breast cancer. In: Mayrovitz HN, ed. Breast cancer. Brisbane (AU)","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"4074_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10549-023-06873-8","volume":"199","author":"AJ Oswald","year":"2023","unstructured":"Oswald AJ, Symeonides SN, Wheatley D, Chan S, Brunt AM, McAdam K, Schmid P, Waters S, Poole C, Twelves C, Perren T, Bartlett J, Piper T, Chisholm EM, Welsh M, Hill R, Hopcroft LEM, Barrett-Lee P, Cameron DA (2023) Aromatase inhibition plus\/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study. Breast Cancer Res Treat 199:35\u201346","journal-title":"Breast Cancer Res Treat"},{"key":"4074_CR62","first-page":"4773","volume":"52","author":"AE Ottenhoff-Kalff","year":"1992","unstructured":"Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE (1992) Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 52:4773\u20134778","journal-title":"Cancer Res"},{"key":"4074_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101893","volume":"41","author":"Y Ou","year":"2024","unstructured":"Ou Y, Wang M, Xu Q, Sun B, Jia Y (2024) Small molecule agents for triple negative breast cancer: current status and future prospects. Transl Oncol 41:101893","journal-title":"Transl Oncol"},{"key":"4074_CR64","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.4161\/15384047.2014.956634","volume":"15","author":"K Penzes","year":"2014","unstructured":"Penzes K, Baumann C, Szabadkai I, Orfi L, Keri G, Ullrich A, Torka R (2014) Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells. Cancer Biol Ther 15:1571\u20131582","journal-title":"Cancer Biol Ther"},{"key":"4074_CR65","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3892\/ijo.2017.4114","volume":"51","author":"SL Phillips","year":"2017","unstructured":"Phillips SL, Williams CB, Zambrano JN, Williams CJ, Yeh ES (2017) Connexin 43 in the development and progression of breast cancer: What\u2019s the connection? (review). Int J Oncol 51:1005\u20131013","journal-title":"Int J Oncol"},{"key":"4074_CR66","doi-asserted-by":"publisher","first-page":"R522","DOI":"10.1186\/bcr1042","volume":"7","author":"MA Pollmann","year":"2005","unstructured":"Pollmann MA, Shao Q, Laird DW, Sandig M (2005) Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 7:R522\u2013R534","journal-title":"Breast Cancer Res"},{"key":"4074_CR67","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1006\/excr.1995.1308","volume":"220","author":"A Pozzi","year":"1995","unstructured":"Pozzi A, Risek B, Kiang DT, Gilula NB, Kumar NM (1995) Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 220:212\u2013219","journal-title":"Exp Cell Res"},{"key":"4074_CR68","doi-asserted-by":"publisher","first-page":"29132","DOI":"10.1074\/jbc.M200797200","volume":"277","author":"H Qin","year":"2002","unstructured":"Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 277:29132\u201329138","journal-title":"J Biol Chem"},{"key":"4074_CR69","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s004320000197","volume":"127","author":"D Reissig","year":"2001","unstructured":"Reissig D, Clement J, Sanger J, Berndt A, Kosmehl H, Bohmer FD (2001) Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. J Cancer Res Clin Oncol 127:226\u2013230","journal-title":"J Cancer Res Clin Oncol"},{"key":"4074_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189173","volume":"1879","author":"M Rodriguez-Candela Mateos","year":"2024","unstructured":"Rodriguez-Candela Mateos M, Carpintero-Fernandez P, Freijanes PS, Mosquera J, Nebril BA, Mayan MD (2024) Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: mechanisms and applications. Biochim Biophys Acta Rev Cancer 1879:189173","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4074_CR71","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jcb.10519","volume":"89","author":"CG Saez","year":"2003","unstructured":"Saez CG, Velasquez L, Montoya M, Eugenin E, Alvarez MG (2003) Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line. J Cell Biochem 89:450\u2013461","journal-title":"J Cell Biochem"},{"key":"4074_CR72","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1021\/bi201806j","volume":"51","author":"A Saidi Brikci-Nigassa","year":"2012","unstructured":"Saidi Brikci-Nigassa A, Clement MJ, Ha-Duong T, Adjadj E, Ziani L, Pastre D, Curmi PA, Savarin P (2012) Phosphorylation controls the interaction of the connexin43 C-terminal domain with tubulin and microtubules. Biochemistry 51:4331\u20134342","journal-title":"Biochemistry"},{"key":"4074_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155607","volume":"263","author":"V Sankarapandian","year":"2024","unstructured":"Sankarapandian V, Rajendran RL, Miruka CO, Sivamani P, Maran BAV, Krishnamoorthy R, Gangadaran P, Ahn BC (2024) A review on tyrosine kinase inhibitors for targeted breast cancer therapy. Pathol Res Pract 263:155607","journal-title":"Pathol Res Pract"},{"key":"4074_CR74","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"4074_CR75","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.12659\/MSM.913479","volume":"24","author":"T Shen","year":"2018","unstructured":"Shen T, Guo Q (2018) Role of Pyk2 in human cancers. Med Sci Monit 24:8172\u20138182","journal-title":"Med Sci Monit"},{"key":"4074_CR76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170953","author":"S Sinha","year":"2024","unstructured":"Sinha S, Callow BW, Farfel AP, Roy S, Chen S, Masotti M, Rajendran S, Buschhaus JM, Espinoza CR, Luker KE, Ghosh P, Luker GD (2024) Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels. J Clin Invest.\u00a0134(24).\u00a0https:\/\/doi.org\/10.1172\/JCI170953","journal-title":"J Clin Invest"},{"key":"4074_CR77","doi-asserted-by":"publisher","unstructured":"Spagnol G, Trease AJ, Zheng L, Gutierrez M, Basu I, Sarmiento C, Moore G, Cervantes M, Sorgen PL\u00a0(2018) Connexin43 carboxyl-terminal domain directly interacts with beta-catenin. Int J Mol Sci. 19(6). https:\/\/doi.org\/10.3390\/ijms19061562","DOI":"10.3390\/ijms19061562"},{"key":"4074_CR78","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/milmed\/usy417","volume":"184","author":"M Srivastava","year":"2019","unstructured":"Srivastava M, Eidelman O, Craig J, Starr J, Kvecher L, Liu J, Hueman M, Pollard HB, Hu H, Shriver CD (2019) Serum biomarkers for racial disparities in breast cancer progression. Mil Med 184:652\u2013657","journal-title":"Mil Med"},{"key":"4074_CR79","doi-asserted-by":"publisher","first-page":"R279","DOI":"10.1530\/REP-14-0661","volume":"149","author":"MK Stewart","year":"2015","unstructured":"Stewart MK, Simek J, Laird DW (2015) Insights into the role of connexins in mammary gland morphogenesis and function. Reproduction 149:R279-290","journal-title":"Reproduction"},{"key":"4074_CR80","first-page":"904","volume":"126","author":"K Stoletov","year":"2013","unstructured":"Stoletov K, Strnadel J, Zardouzian E, Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR, Klemke RL (2013) Role of connexins in metastatic breast cancer and melanoma brain colonization. J Cell Sci 126:904\u2013913","journal-title":"J Cell Sci"},{"key":"4074_CR81","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3892\/ijo.2012.1524","volume":"41","author":"Y Sun","year":"2012","unstructured":"Sun Y, Zhao X, Yao Y, Qi X, Yuan Y, Hu Y (2012) Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. Int J Oncol 41:941\u2013948","journal-title":"Int J Oncol"},{"key":"4074_CR82","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1016\/j.yexcr.2008.07.030","volume":"314","author":"RS Talhouk","year":"2008","unstructured":"Talhouk RS, Mroue R, Mokalled M, Abi-Mosleh L, Nehme R, Ismail A, Khalil A, Zaatari M, El-Sabban ME (2008) Heterocellular interaction enhances recruitment of alpha and beta-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells. Exp Cell Res 314:3275\u20133291","journal-title":"Exp Cell Res"},{"key":"4074_CR83","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.yexcr.2013.10.002","volume":"319","author":"RS Talhouk","year":"2013","unstructured":"Talhouk RS, Fares MB, Rahme GJ, Hariri HH, Rayess T, Dbouk HA, Bazzoun D, Al-Labban D, El-Sabban ME (2013) Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of beta-catenin\/connexin43 association. Exp Cell Res 319:3065\u20133080","journal-title":"Exp Cell Res"},{"key":"4074_CR84","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1073\/pnas.96.4.1415","volume":"96","author":"DA Tice","year":"1999","unstructured":"Tice DA, Biscardi JS, Nickles AL, Parsons SJ (1999) Mechanism of biological synergy between cellular Src and Epidermal Growth Factor Receptor. Proc Natl Acad Sci U S A 96:1415\u20131420","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4074_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166812","volume":"1869","author":"MZ Totland","year":"2023","unstructured":"Totland MZ, Omori Y, Sorensen V, Kryeziu K, Aasen T, Brech A, Leithe E (2023) Endocytic trafficking of connexins in cancer pathogenesis. Biochim Biophys Acta Mol Basis Dis 1869:166812","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4074_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2021.1962698","volume":"10","author":"YC Unal","year":"2022","unstructured":"Unal YC, Yavuz B, Ozcivici E, Mese G (2022) The role of connexins in breast cancer: from misregulated cell communication to aberrant intracellular signaling. Tissue Barriers 10:1962698","journal-title":"Tissue Barriers"},{"key":"4074_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14171875","author":"VB Varzaru","year":"2024","unstructured":"Varzaru VB, Vlad T, Popescu R, Vlad CS, Moatar AE, Cobec IM (2024) Triple-negative breast cancer: molecular particularities still a challenge. Diagnostics Basel.\u00a014(17).\u00a0https:\/\/doi.org\/10.3390\/diagnostics14171875","journal-title":"Diagnostics Basel"},{"key":"4074_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N","volume":"180","author":"BS Verbeek","year":"1996","unstructured":"Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, Rijksen G (1996) c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180:383\u2013388","journal-title":"J Pathol"},{"key":"4074_CR89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/0008-5472.CAN-16-1797","volume":"77","author":"N Verma","year":"2017","unstructured":"Verma N, Muller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S (2017) Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 axis. Cancer Res 77:86\u201399","journal-title":"Cancer Res"},{"key":"4074_CR90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1574362409666140206221931","volume":"8","author":"V von Manstein","year":"2013","unstructured":"von Manstein V, Yang CM, Richter D, Delis N, Vafaizadeh V, Groner B (2013) Resistance of cancer cells to targeted therapies through the activation of compensating signaling loops. Curr Signal Transduct Ther 8:193\u2013202","journal-title":"Curr Signal Transduct Ther"},{"key":"4074_CR91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.21037\/apm-25-30","volume":"14","author":"B Wang","year":"2025","unstructured":"Wang B, He X, Dutta S, Chen S, Liang J, Huang W, Ahmad W, Xu M, Wang Y (2025) New progress and challenges of targeted therapies for breast cancer. Ann Palliat Med 14:345\u2013352","journal-title":"Ann Palliat Med"},{"key":"4074_CR92","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1093\/cvr\/cvab364","volume":"118","author":"AD Wilson","year":"2022","unstructured":"Wilson AD, Richards MA, Curtis MK, Gunadasa-Rohling M, Monterisi S, Loonat AA, Miller JJ, Ball V, Lewis A, Tyler DJ, Moshnikova A, Andreev OA, Reshetnyak YK, Carr C, Swietach P (2022) Acidic environments trigger intracellular H+-sensing FAK proteins to re-balance sarcolemmal acid-base transporters and auto-regulate cardiomyocyte pH. Cardiovasc Res 118:2946\u20132959","journal-title":"Cardiovasc Res"},{"key":"4074_CR93","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.7150\/ijbs.55453","volume":"17","author":"DP Wu","year":"2021","unstructured":"Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX (2021) Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src\/PI3K\/Akt pathway. Int J Biol Sci 17:2380\u20132398","journal-title":"Int J Biol Sci"},{"key":"4074_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021527","volume":"6","author":"F Xiao","year":"2011","unstructured":"Xiao F, Weng J, Fan K, Wang W (2011) Detailed regulatory mechanism of the interaction between ZO-1 PDZ2 and connexin43 revealed by MD simulations. PLoS ONE 6:e21527","journal-title":"PLoS ONE"},{"key":"4074_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1405491","volume":"14","author":"N Xiong","year":"2024","unstructured":"Xiong N, Wu H, Yu Z (2024) Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies. Front Oncol 14:1405491","journal-title":"Front Oncol"},{"key":"4074_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R (2024) Wnt\/beta-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci 81:79","journal-title":"Cell Mol Life Sci"},{"issue":"Pt 17","key":"4074_CR97","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1242\/jcs.113.17.3063","volume":"113","author":"J Zhao","year":"2000","unstructured":"Zhao J, Zheng C, Guan J (2000) Pyk2 and FAK differentially regulate progression of the cell cycle. J Cell Sci 113(Pt 17):3063\u20133072","journal-title":"J Cell Sci"},{"key":"4074_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149231","volume":"11","author":"M Zhao","year":"2016","unstructured":"Zhao M, Finlay D, Zharkikh I, Vuori K (2016) Novel role of Src in priming Pyk2 phosphorylation. PLoS ONE 11:e0149231","journal-title":"PLoS ONE"},{"key":"4074_CR99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2018.11.008","volume":"126","author":"L Zheng","year":"2019","unstructured":"Zheng L, Li H, Cannon A, Trease AJ, Spagnol G, Zheng H, Radio S, Patel K, Batra S, Sorgen PL (2019) Phosphorylation of Cx43 residue Y313 by Src contributes to blocking the interaction with drebrin and disassembling gap junctions. J Mol Cell Cardiol 126:36\u201349","journal-title":"J Mol Cell Cardiol"},{"key":"4074_CR100","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yjmcc.2020.09.004","volume":"149","author":"L Zheng","year":"2020","unstructured":"Zheng L, Trease AJ, Katsurada K, Spagnol G, Li H, Shi W, Duan B, Patel KP, Sorgen PL (2020) Inhibition of Pyk2 and Src activity improves Cx43 gap junction intercellular communication. J Mol Cell Cardiol 149:27\u201340","journal-title":"J Mol Cell Cardiol"},{"key":"4074_CR101","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010294","volume":"16","author":"L Zheng","year":"2023","unstructured":"Zheng L, Spagnol G, Gandhi DR, Sharma K, Kumar V, Patel KP, Sorgen PL (2023) Inhibition of Pyk2 improves Cx43 intercalated disc localization, infarct size, and cardiac function in rats with heart failure. Circ Heart Fail 16:e010294","journal-title":"Circ Heart Fail"},{"key":"4074_CR102","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s13238-016-0288-z","volume":"7","author":"X Zhou","year":"2016","unstructured":"Zhou X, Lei QY (2016) Regulation of TAZ in cancer. Protein Cell 7:548\u2013561","journal-title":"Protein Cell"},{"key":"4074_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10050139","author":"X Zhu","year":"2018","unstructured":"Zhu X, Bao Y, Guo Y, Yang W (2018) Proline-rich protein tyrosine kinase 2 in inflammation and cancer. Cancers (Basel).\u00a010(5).\u00a0https:\/\/doi.org\/10.3390\/cancers10050139","journal-title":"Cancers (Basel)"},{"key":"4074_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31278","volume":"239","author":"Z Zou","year":"2024","unstructured":"Zou Z, Luo T, Wang X, Wang B, Li Q (2024) Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies. J Cell Physiol 239:e31278","journal-title":"J Cell Physiol"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-026-04074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00441-026-04074-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-026-04074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:06:37Z","timestamp":1779944797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00441-026-04074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4074"],"URL":"https:\/\/doi.org\/10.1007\/s00441-026-04074-5","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}